Similar Posts
A Simple Tweak Makes Calorie Labeling More Effective
Byadmin“A Simple Tweak Makes Calorie Labeling More Effective” – The Washington Post
Healthcare Unaffordable? Perhaps Your Doctor Is Partly to Blame
ByadminHere is a news article from Canada, experiencing the kind of healthcare inflation that causes them to call experts in the U.S. for advice—people like me, but also some actual credible authorities! Some see it as an eternal struggle: the goodhearted doctor championing the best treatments, no matter the cost, while doing battle against the…
In Medical Market, Shoppers Lack Savvy
ByadminEven before Obamacare became the law of the land, the U.S. health care system was undergoing a dramatic transformation. Millions of people were shifting from generous health insurance plans to consumer-directed ones that pair low monthly premiums with high out-of-pocket costs. This shift has been encouraged by employers, eager to reduce the cost of employee…
A Drug to Treat Cancer and Heart Disease (Miracle Cure or Media Hype?)
ByadminIn a recent New York Times article, physician-author Siddhartha Mukherjee wrote about a clinical trial that he characterized as “beautiful,” for potentially illuminating a surprising connection between heart disease and cancer. Mukherjee is a justifiably acclaimed writer, who publishes regularly in The New Yorkerand The New York Times, and who won a Pulitzer for his bestselling book The Emperor of All Maladies. But…
The Psychology of Entrepreneurial Success
ByadminIn a recent post, I give you a flavor for Rich Cohen’s wonderful book The Fish That Ate the Whale. One of the things that struck me in reading his book was the psychology of entrepreneurial success. It is often difficult to be a superstar entrepreneur if you are realistic. Often the biggest successes in…
How a Leading Medical Journal Helped a Pharmaceutical Company Exaggerate Medication Benefits
ByadminShutterstock How excited would you be about a medication that lowered your risk of cardiovascular death, heart attack, or stroke by 1.5%? Excited enough to spend a few thousand dollars a year on the drug? I expect not. What if, instead, the drug reduced those same terrible outcomes by 20%? That’s probably enough benefit to…

